373 related articles for article (PubMed ID: 30922302)
1. Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts.
Lee SH; Lee JH; Yoon HI; Park HY; Kim TH; Yoo KH; Oh YM; Jung KS; Lee SD; Lee SW
Respir Res; 2019 Mar; 20(1):62. PubMed ID: 30922302
[TBL] [Abstract][Full Text] [Related]
2. Comparative Effectiveness of Long-Acting Beta
Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
[TBL] [Abstract][Full Text] [Related]
3. "Real-life" inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD.
Vogelmeier C; Worth H; Buhl R; Criée CP; Lossi NS; Mailänder C; Kardos P
Int J Chron Obstruct Pulmon Dis; 2017; 12():487-494. PubMed ID: 28203072
[TBL] [Abstract][Full Text] [Related]
4. Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD).
Chalmers JD; Poole C; Webster S; Tebboth A; Dickinson S; Gayle A
Respir Res; 2018 Apr; 19(1):63. PubMed ID: 29642882
[TBL] [Abstract][Full Text] [Related]
5. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.
Watz H; Tetzlaff K; Wouters EF; Kirsten A; Magnussen H; Rodriguez-Roisin R; Vogelmeier C; Fabbri LM; Chanez P; Dahl R; Disse B; Finnigan H; Calverley PM
Lancet Respir Med; 2016 May; 4(5):390-8. PubMed ID: 27066739
[TBL] [Abstract][Full Text] [Related]
6. Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO).
Rossi A; Guerriero M; Corrado A;
Respir Res; 2014 Jul; 15(1):77. PubMed ID: 25005873
[TBL] [Abstract][Full Text] [Related]
7. Withdrawal of Inhaled Corticosteroids from Patients with COPD; Effect on Exacerbation Frequency and Lung Function: A Systematic Review.
Georgiou A; Ramesh R; Schofield P; White P; Harries TH
Int J Chron Obstruct Pulmon Dis; 2024; 19():1403-1419. PubMed ID: 38919905
[TBL] [Abstract][Full Text] [Related]
8. Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice.
Chalmers JD; Tebboth A; Gayle A; Ternouth A; Ramscar N
NPJ Prim Care Respir Med; 2017 Jun; 27(1):43. PubMed ID: 28663549
[TBL] [Abstract][Full Text] [Related]
9. Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice.
Kaplan AG
Int J Chron Obstruct Pulmon Dis; 2015; 10():2535-48. PubMed ID: 26648711
[TBL] [Abstract][Full Text] [Related]
10. Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study.
Magnussen H; Lucas S; Lapperre T; Quint JK; Dandurand RJ; Roche N; Papi A; Price D; Miravitlles M;
Respir Res; 2021 Jan; 22(1):25. PubMed ID: 33478491
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study.
Suissa S; Dell'Aniello S; Ernst P
Lancet Respir Med; 2018 Nov; 6(11):855-862. PubMed ID: 30343028
[TBL] [Abstract][Full Text] [Related]
12. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
[TBL] [Abstract][Full Text] [Related]
13. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
[TBL] [Abstract][Full Text] [Related]
14. Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey.
Ding B; Small M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1753-1763. PubMed ID: 28670116
[TBL] [Abstract][Full Text] [Related]
15. Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline.
Ferguson GT; Shaikh A; Tetzlaff K; Mueller A; Magnussen H; Watz H
Int J Chron Obstruct Pulmon Dis; 2020; 15():2879-2888. PubMed ID: 33204084
[TBL] [Abstract][Full Text] [Related]
16. The Effect on Total Mortality of Adding Inhaled Corticosteroids to Long-Acting Bronchodilators for COPD: A Real Practice Analysis in Italy.
Di Martino M; Agabiti N; Cascini S; Kirchmayer U; Bauleo L; Fusco D; Belleudi V; Pinnarelli L; Voci C; Patorno E; Pistelli R; Davoli M;
COPD; 2016 Jun; 13(3):293-302. PubMed ID: 26514912
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB
Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological approach and adherence to treatment recommendations in frequently and non-frequently exacerbating COPD patients from Italy: MISTRAL - The prospective cohort, observational study.
Scalone G; Nava S; Ventrella F; Bussoli G; Catapano GA; Pennisi A; Dadduzio F; Schino P; Pela R; Bartezaghi M; Morini P; Porpiglia PA; Muscianisi E;
Pulm Pharmacol Ther; 2018 Dec; 53():68-77. PubMed ID: 30193866
[TBL] [Abstract][Full Text] [Related]
19. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
Postma DS; Roche N; Colice G; Israel E; Martin RJ; van Aalderen WM; Grigg J; Burden A; Hillyer EV; von Ziegenweidt J; Gopalan G; Price D
Int J Chron Obstruct Pulmon Dis; 2014; 9():1163-86. PubMed ID: 25378918
[TBL] [Abstract][Full Text] [Related]
20. The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease.
Souliotis K; Silva Miguel L; Hillas G; Borges M; Papageorgiou G; Viana D; Malhadeiro J; Soulard S
Ther Adv Respir Dis; 2020; 14():1753466620926802. PubMed ID: 32519591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
